North Carolina officials are expected to announce another major corporate deal as early as Monday — one that could bring an ...

Deutsche Bank AG boosted its stake in Regeneron Pharmaceuticals by nearly 22% in Q4, now holding 539,269 shares valued at ...

New Paltz High School senior Joseph Birnbaum was named a scholar in the Regeneron Science Talent Search (STS) for his ...

Nearly 1,700 of the brightest high school students from around the world are heading to Columbus this week to compete in ISEF ...

We recently published a list of 10 Worst Blue Chip Stocks to Buy. In this article, we are going to take a look at where ...

The new plans are in addition to $21B that the drug manufacturer has already committed to U.S. research, development and ...

We recently compiled a list of the 10 Jim Cramer Stocks with Huge Upside Potential. In this article, we are going to take a ...

Despite a risk for severe side effects, pembrolizumab has a record of improving recurrence-free survival that makes it an appealing treatment for advanced melanoma.

Regeneron Pharmaceuticals Inc. closed 54.78% below its 52-week high of $1,211.20, which the company reached on August 27th.

We recently compiled a list of the 11 Cheap ESG Stocks to Buy According to Hedge Funds. In this article, we are going to take ...

Four Gatton Academy of Mathematics and Science students presented their research at the Louisville Regional Science and ...

Schonfeld Strategic Advisors made a bold biotech play by boosting its Regeneron holdings by over 475% in Q4. The firm added ...